SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022799
Filing Date
2017-11-08
Accepted
2017-11-08 16:41:53
Documents
53
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nvus-10q_20170930.htm 10-Q 1245066
2 EX-31.1 nvus-ex311_9.htm EX-31.1 11349
3 EX-31.2 nvus-ex312_7.htm EX-31.2 11492
4 EX-32.1 nvus-ex321_8.htm EX-32.1 7495
5 EX-32.2 nvus-ex322_6.htm EX-32.2 7873
  Complete submission text file 0001564590-17-022799.txt   4279755

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvus-20170930.xml EX-101.INS 776803
7 XBRL TAXONOMY EXTENSION SCHEMA nvus-20170930.xsd EX-101.SCH 40514
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvus-20170930_cal.xml EX-101.CAL 39698
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvus-20170930_def.xml EX-101.DEF 117700
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvus-20170930_lab.xml EX-101.LAB 278728
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvus-20170930_pre.xml EX-101.PRE 215670
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 171187155
SIC: 2834 Pharmaceutical Preparations